×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NTRP – nexttrip, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NTRP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/3
09:09 am
ntrp
NextTrip Closes Acquisition of GoUSA TV Assets, Expanding Strategic Media Footprint and Strengthening the "Media-to-Travel" Ecosystem [Yahoo! Finance Canada]
Low
Report
NextTrip Closes Acquisition of GoUSA TV Assets, Expanding Strategic Media Footprint and Strengthening the "Media-to-Travel" Ecosystem [Yahoo! Finance Canada]
1/14
07:11 pm
ntrp
NextTrip, Inc. Reports Third Quarter 2026 Financial Results [Yahoo! Finance]
High
Report
NextTrip, Inc. Reports Third Quarter 2026 Financial Results [Yahoo! Finance]
1/14
04:45 pm
ntrp
NextTrip, Inc. Reports Third Quarter 2026 Financial Results [Yahoo! Finance Canada]
Medium
Report
NextTrip, Inc. Reports Third Quarter 2026 Financial Results [Yahoo! Finance Canada]
12/10
10:23 am
ntrp
NextTrip Tackles Travel's Biggest Frustration: Why Finding a Hotel Takes Longer Than the Flight There [Yahoo! Finance Canada]
Medium
Report
NextTrip Tackles Travel's Biggest Frustration: Why Finding a Hotel Takes Longer Than the Flight There [Yahoo! Finance Canada]
12/4
09:04 am
ntrp
NextTrip's JOURNY Expands Global Reach with Launch on Apple iOS, Roku, and Android [Yahoo! Finance Canada]
High
Report
NextTrip's JOURNY Expands Global Reach with Launch on Apple iOS, Roku, and Android [Yahoo! Finance Canada]
11/25
01:54 pm
ntrp
NextTrip (NASDAQ:NTRP) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
NextTrip (NASDAQ:NTRP) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
11/20
08:11 am
ntrp
Vanderbilt Report: How Gaming Veterans are Fixing Travel's $8 Billion Conversion Problem [Yahoo! Finance Canada]
Low
Report
Vanderbilt Report: How Gaming Veterans are Fixing Travel's $8 Billion Conversion Problem [Yahoo! Finance Canada]
11/19
09:24 am
ntrp
NextTrip signs LOI and enters exclusive discussions to acquire GoUSA TV platform [Seeking Alpha]
Medium
Report
NextTrip signs LOI and enters exclusive discussions to acquire GoUSA TV platform [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/3
09:02 am
ntrp
Form 8-K NextTrip, Inc. For: Feb 03
Low
Report
Form 8-K NextTrip, Inc. For: Feb 03
1/14
04:51 pm
ntrp
Form 10-Q NextTrip, Inc. For: Nov 30
High
Report
Form 10-Q NextTrip, Inc. For: Nov 30
1/14
04:31 pm
ntrp
Form 8-K NextTrip, Inc. For: Jan 14
High
Report
Form 8-K NextTrip, Inc. For: Jan 14
12/29
06:02 am
ntrp
Form 8-K NextTrip, Inc. For: Dec 23
Medium
Report
Form 8-K NextTrip, Inc. For: Dec 23
12/4
09:01 am
ntrp
Form 8-K NextTrip, Inc. For: Dec 04
High
Report
Form 8-K NextTrip, Inc. For: Dec 04
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/21
Form 8-K Neurotrope, Inc. For: Jan 17
14.2%
8/5 Neurotrope Announces Corporate Update and Reports Second Quarter 2019 Financial Results 11.8%
8/5 Form 8-K Neurotrope, Inc. For: Aug 05 10.6%
6/18 Neurotrope Inc (NASDAQ: NTRP) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating on the stock. 5.8%
8/21 Neurotrope Inc (NASDAQ: NTRP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $6.50 price target on the stock. 5.6%
7/17 Neurotrope's Bryostatin Is Unlikely To Produce Significant Cognitive Efficacy [Seeking Alpha] 3.8%
6/5 Form DEF 14A Neurotrope, Inc. For: Jul 23 3.2%
5/30 Neurotrope to Present at the LD Micro 9th Annual Invitational Conference on June 4, 2019 2.9%
10/25 Neurotrope Inc (NASDAQ: NTRP) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.9%
6/24 Neurotrope CEO to Present at the Maxim Group Key Opinion Leader Discussion on Alzheimer's Disease on June 26th, 2019 2.6%
8/5 Neurotrope Announces Corporate Update and Reports Second Quarter 2019 Financial Results 11.8%
8/5 Form 8-K Neurotrope, Inc. For: Aug 05 10.6%
6/18 Neurotrope Inc (NASDAQ: NTRP) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating on the stock. 5.8%
8/21 Neurotrope Inc (NASDAQ: NTRP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $6.50 price target on the stock. 5.6%
7/17 Neurotrope's Bryostatin Is Unlikely To Produce Significant Cognitive Efficacy [Seeking Alpha] 3.8%
6/5 Form DEF 14A Neurotrope, Inc. For: Jul 23 3.2%
5/30 Neurotrope to Present at the LD Micro 9th Annual Invitational Conference on June 4, 2019 2.9%
10/25 Neurotrope Inc (NASDAQ: NTRP) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.9%
6/24 Neurotrope CEO to Present at the Maxim Group Key Opinion Leader Discussion on Alzheimer's Disease on June 26th, 2019 2.6%
TOP News Decliners
1/22
Neurotrope, Inc. Announces $18 Million Registered Direct Offering
-47.6%
3/13 Form 10-K Neurotrope, Inc. For: Dec 31 -11.7%
8/13 Neurotrope Announces Publication Highlighting the Potential of Bryostatin as a Unique Neurorestorative Therapy -11.5%
10/8 Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder Value -9.3%
7/11 Neurotrope to Present at the Alzheimer's Association International Conference; Neurotrope President and Chief Scientific Officer, Dr. Daniel L. Alkon, to Receive Cure Coin Award; Design of Confirmatory Phase 2 Trial to be Presented -9.0%
8/26 Form S-8 Neurotrope, Inc. -9.0%
3/24 Form 4 Neurotrope, Inc. For: Mar 20 Filed by: Bernstein Bruce -6.8%
8/8 Q2/2019 6/30/2019 EPS 0.310 ZacksConsensus -0.380 ActVsEst 0.690 - Beat -5.4%
12/16 Form 4 Neurotrope, Inc. For: Dec 13 Filed by: Ryan Charles S. -4.7%
4/17 Form S-3 Neurotrope, Inc. -4.0%
3/13 Form 10-K Neurotrope, Inc. For: Dec 31 -11.7%
8/13 Neurotrope Announces Publication Highlighting the Potential of Bryostatin as a Unique Neurorestorative Therapy -11.5%
10/8 Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder Value -9.3%
7/11 Neurotrope to Present at the Alzheimer's Association International Conference; Neurotrope President and Chief Scientific Officer, Dr. Daniel L. Alkon, to Receive Cure Coin Award; Design of Confirmatory Phase 2 Trial to be Presented -9.0%
8/26 Form S-8 Neurotrope, Inc. -9.0%
3/24 Form 4 Neurotrope, Inc. For: Mar 20 Filed by: Bernstein Bruce -6.8%
8/8 Q2/2019 6/30/2019 EPS 0.310 ZacksConsensus -0.380 ActVsEst 0.690 - Beat -5.4%
12/16 Form 4 Neurotrope, Inc. For: Dec 13 Filed by: Ryan Charles S. -4.7%
4/17 Form S-3 Neurotrope, Inc. -4.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: